Colorectal Cancer Screening and Diagnostics Market

The Colorectal Cancer Screening and Diagnostics Market was valued at USD 40 Billion in 2024, and is projected to reach USD 46.1 Billion by 2029, rising at a CAGR of 2.90%.

The increasing incidence of colorectal cancer, rise in demand for non-invasive colorectal cancer screening, growing need for early cancer detection to lower treatment cost, advances in genomics and molecular diagnostics, and rising financial burden on healthcare are key factors driving the market’s growth. However, the limited sensitivity of non-invasive testing methods, sample collection challenges, and stringent regulations might hinder the market’s growth in the next five years.

This report segments the global market by test type, end user, and region. By test type, the colonoscopy and sigmoidoscopy segment held the largest market share in 2023, and this segment is expected to grow at a CAGR of 1.7% during the forecast period.

In terms of end users, the hospital and clinic segment is forecast to grow at a CAGR of 2.6% during the forecast period. This segment dominated with 69.3% of the market in 2023 and is forecast to reach a value of $31.4 billion by the end of 2029.

North America held the largest regional market share, with 60.8% in 2023. An increasing number of screening tests for colorectal cancer coupled with the significant regional presence of key product manufacturers are responsible for a large share.

Leading product manufacturers in the global market include Fujifilm Holdings Corp., Olympus Corp., Exact Sciences Corp., Danaher Corp., Guardant Health, and New Horizon Health.

Report Scope

This report summarizes the colorectal cancer screening and diagnostic testing service market, including a market snapshot and company profiles of leading product manufacturers/service providers. It provides a comprehensive market breakdown with in-depth information regarding each segment. The overview section of the report describes market trends and dynamics, including drivers, challenges, and opportunities. It provides information on emerging technologies and developments in the industry. The report also analyzes critical market players' financials, product portfolios, and recent activities.

The publisher analyzed and made projections of each market and its applications, along with forecasts for the next five years. The report also features profiles of leading product manufacturers/service providers in the colorectal cancer screening and diagnostic testing service industry, including Fujifilm Holdings Corporation, Olympus Corporation, Exact Sciences Corporation, Danaher Corporation, Guardant Health, New Horizon Health, and Quest Diagnostics.

The market is segmented by geographical region into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

Regional analysis is further segregated:

North America: The U.S., Canada, and Mexico
Europe: Germany, the U.K., France, Italy, Spain, and the Rest of Europe
Asia-Pacific: China, Japan, India, South Korea, Australia, and the Rest of Asia-Pacific

Data for market estimates have been provided for 2021 and 2022 as the historical years and 2023 as the base year, with the forecast through 2029.

The report includes:

37 data tables and 71 additional tables
Analyses of trends in the global market for colorectal cancer screening and diagnostics, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
Estimates and forecasts of the market size by type, end user and geographic region
Discussion of emerging technologies and developments, and the macroeconomic factors affecting the market
Coverage of stages, etiology, pathophysiology, and risk factors of colorectal cancer, and discussion on its diagnosis, regulatory framework and reimbursement scenarios
Information on product pipeline, approvals, launches and expansions and funding and grants in the medical industry
Review of patent data and other new developments
Discussion of ESG challenges and practices of the industry
Assessment of the competitive landscape, including the market shares of leading companies, their product portfolios and financial overviews
Information on recent mergers and acquisitions, expansions, collaborations, investments, and divestments
Company profiles of major players within the industry, including Fujifilm Holdings Corp., Olympus Corp., Exact Sciences Corp., Danaher Corp., and Guardant Health

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Insights

Chapter 2 Market Overview

Disease Area Overview
Stages of Colorectal Cancer
Stage 0
Stage I
Stage II
Stage III
Stage IV
Etiology
Genetic Factors
Environmental Factors
Pathophysiology
Germline Mutations
Sporadic Mutations
Metastasis
Clinical Implications
Risk Factors
Inherited Syndromes
Lynch Syndrome (HNPCC)
Familial Adenomatous Polyposis (FAP)
Diagnosis
Prognosis
Types of Colorectal Cancer
Colorectal Adenocarcinoma
Gastrointestinal Stromal Tumors (GISTs)
Carcinoids
Turcot Syndrome
Peutz-Jeghers Syndrome (PJS)
Familial Colorectal Cancer (FCC)
Juvenile Polyposis Syndrome (JPS)
Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)
MUTYH-Associated Polyposis (MAP)
Market Definition
Inclusion and Exclusion Criteria
Inclusion Criteria
Exclusion Criteria
Market Introduction
The Road Ahead
Global Prevalence of Colorectal Cancer
Industry Outlook: Regulatory Framework
Regulatory Framework in the U.S.
Regulatory Framework in Europe
Regulatory Framework in the Asia-Pacific Region
Regulatory Landscape in Latin America
Reimbursement Scenarios
Colonoscopy and Sigmoidoscopy Tests
Stool DNA Test
Fecal Immunochemical Tests (FIT)
Fecal Occult Blood Tests (FOBT)
Blood-based/Biomarker Tests
Product Pipeline
Comparison of Colorectal Cancer Screening and Diagnostic Tests
Colonoscopy Tests
Sigmoidoscopy Tests
Fecal Immunochemical Tests (FIT)
Guaiac Fecal Occult Blood Tests (gFOBT)
Stool DNA Tests

Chapter 3 Market Dynamics

Market Dynamics Snapshot
Market Drivers
Increasing Incidence of Colorectal Cancer
Growing Financial Burden
Advances in Genomics and Molecular Diagnostics
Rise in Demand for Non-Invasive Colorectal Cancer Screening
Growing Need for Early Cancer Detection to Lower Treatment Costs
Market Restraints
Limited Sensitivity of Non-Invasive Testing Methods
Sample Collection Challenges
Stringent Regulations
Market Opportunities
Global Expansion of Colorectal Cancer Screening Programs
Emerging Economies Proposing Significant Untapped Potential

Chapter 4 Emerging Technologies and Developments

Introduction
Multimodal Approaches to Colorectal Cancer Screening
Development of At-Home Colorectal Cancer Screening Kits
Emerging Use of Gut Microbiota in Colorectal Cancer Diagnosis
Adoption of Artificial Intelligence (AI)
Digital Health Interventions
Multicancer Detection (MCD) Assays
Development of Self-Propelled Colonoscopes
Aer-O-Scope Colonoscope
ColonoSight

Chapter 5 Market Segmentation Analysis

Key Market Trends
Segmentation Breakdown
Global Market for Colorectal Cancer Screening and Diagnostic Testing Services
Market Analysis by Test Type
Colonoscopy and Sigmoidoscopy Tests
Stool DNA Tests
Market Size and Forecast
Blood-Based/Biomarker Tests
Fecal Occult Blood Tests (FOBT)
Fecal Immunochemical Tests (FIT)
Market Analysis by End User
Hospitals and Clinics
Diagnostic Laboratories
Ambulatory Centers
At-home Care
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific Region
Rest of the World

Chapter 6 Competitive Intelligence

Competitive Landscape
Partnerships and Collaborations
Acquisitions
Business Expansions
Funding and Grants
Product Approvals, Launches and Expansions
Regulatory and Legal Activities
Medicare and Insurance Coverage

Chapter 7 Sustainability in the Colorectal Cancer Screening and Diagnostic Testing Service Market

Introduction
Sustainability
Concluding Remarks

Chapter 8 Appendix

Methodology
Sources
Abbreviations
Company Profiles
DANAHER CORP.
DIACARTA
EIKEN CHEMICAL CO. LTD.
EXACT SCIENCES CORP.
FREENOME HOLDINGS INC.
FUJIFILM HOLDINGS CORP.
GI-VIEW
GUARDANT HEALTH
HANGZHOU NOVAHEALTH TECHNOLOGY CO. LTD.
LABORATORY CORPORATION OF AMERICA HOLDINGS
LEPU MEDICAL TECHNOLOGY (BEIJING) CO. LTD.
MAINZ BIOMED N.V.
NOVIGENIX SA
OLYMPUS CORP.
QUEST DIAGNOSTICS INC.
QUIDELORTHO CORP.

List of Tables

Summary Table Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 1 Stage II Substages of Colorectal Cancer
Table 2 Stage III Substages of Colorectal Cancer
Table 3 Stage IV Substages of Colorectal Cancer
Table 4 Regulatory Landscape for Different Parameters for Key Countries
Table 5 Colonoscopy and Sigmoidoscopy Test Reimbursements, by Country, 2024
Table 6 Stool DNA Test Reimbursements, by Country, 2024
Table 7 Fecal Immunochemical Test Reimbursements, by Country, 2024
Table 8 Fecal Occult Blood Test Reimbursements, by Country, 2024
Table 9 Blood-based/Biomarker Test Reimbursements, by Country, 2024
Table 10 Cancer Screening and Diagnostic Product Pipeline, 2024
Table 11 Characteristics of CRC Screening Tests Currently Available in the U.S., 2024
Table 12 Characteristics of Recommended Colorectal Cancer Screening Tests, 2024
Table 13 Countries with Highest Colorectal Cancer Incidence and Rates, 2022
Table 14 Successful Colorectal Cancer Screening Initiatives, 2004-2011
Table 15 Examples of Product Launches and Approval in the Asia-Pacific Region, 2022
Table 16 Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, Through 2029
Table 17 Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029
Table 18 Global Market for Colonoscopy and Sigmoidoscopy Tests, by Region, Through 2029
Table 19 Global Market for Stool DNA Tests, by Region, Through 2029
Table 20 Global Market for Blood-Based/Biomarker Tests, by Region, Through 2029
Table 21 Global Market for Fecal Occult Blood Tests (FOBT), by Region, Through 2029
Table 22 Global Market for Fecal Immunochemical Tests (FIT), by Region, Through 2029
Table 23 Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by End User, Through 2029
Table 24 Global Market for Hospitals and Clinics in Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 25 Global Market for Diagnostic Laboratories in Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 26 Global Market for Ambulatory Centers in Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 27 Global Market for At-home Care in Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 28 Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 29 North American Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Country, Through 2029
Table 30 North American Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029
Table 31 North American Market for Colorectal Cancer Screening and Diagnostic Testing Services, by End User, Through 2029
Table 32 European Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Country, Through 2029
Table 33 European Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029
Table 34 European Market for Colorectal Cancer Screening and Diagnostic Testing Services, by End User, Through 2029
Table 35 Asia-Pacific Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Country, Through 2029
Table 36 Asia-Pacific Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029
Table 37 Asia-Pacific Market for Colorectal Cancer Screening and Diagnostic Testing Services, by End User, Through 2029
Table 38 ROW Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029
Table 39 ROW Market for Colorectal Cancer Screening and Diagnostic Testing Services, by End User, Through 2029
Table 40 Top Products and Their Manufacturers in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2023
Table 41 Select Strategic Alliances in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024
Table 42 Select Acquisitions in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024
Table 43 Major Business Expansion Activities in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024
Table 44 Major Grants and Funding Activities in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024
Table 45 Major Product Approvals, Launches, and Expansions in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024
Table 46 Major Regulatory and Legal Activities in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2024
Table 47 Major Medicare and Insurance Coverage in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024
Table 48 Recent ESG Highlights from Select Testing Services Providing Companies
Table 49 ESG Rankings for a Few Service-Providing Companies, 2024
Table 50 ESG Rankings for Major Product Manufacturing Companies, 2024
Table 51 Information Sources for this Report
Table 52 Glossary of Terms Used in the Colorectal Cancer Screening and Diagnostic Testing Service Market
Table 53 Danaher Corp.: Company Snapshot
Table 54 Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 55 Danaher Corp.: Product Portfolio
Table 56 Danaher Corp.: News/Key Developments, 2022
Table 57 DiaCarta: Company Snapshot
Table 58 DiaCarta: Product Portfolio
Table 59 DiaCarta: News/Key Developments, 2023
Table 60 Eiken Chemical Co. Ltd.: Company Snapshot
Table 61 Eiken Chemical Co. Ltd.: Financial Performance, FY 2022 and 2023
Table 62 Eiken Chemical Co. Ltd.: Product Portfolio
Table 63 Eiken Chemical Co. Ltd.: News/Key Developments, 2022
Table 64 Exact Sciences Corp.: Company Snapshot
Table 65 Exact Sciences Corp.: Financial Performance, FY 2022 and 2023
Table 66 Exact Sciences Corp.: Product Portfolio
Table 67 Exact Sciences Corp.: News/Key Developments, 2022-2024
Table 68 Freenome Holdings Inc.: Company Snapshot
Table 69 Freenome Holdings Inc.: News/ Key Developments, 2023 and 2024
Table 70 Fujifilm Holdings Corp.: Company Snapshot
Table 71 Fujifilm Holdings Corp.: Financial Performance, FY 2022 and 2023
Table 72 Fujifilm Holdings Corp.: Product Portfolio
Table 73 GI-View: Company Snapshot
Table 74 GI-View: Product Portfolio
Table 75 Guardant Health: Company Snapshot
Table 76 Guardant Health: Financial Performance, FY 2022 and 2023
Table 77 Guardant Health: Product Portfolio
Table 78 Guardant Health: News/Key Developments, 2024
Table 79 Hangzhou NovaHealth Technology Co. Ltd.: Company Snapshot
Table 80 Hangzhou NovaHealth Technology Co. Ltd.: Financial Performance, FY 2021 and 2022
Table 81 Hangzhou NovaHealth Technology Co. Ltd.: Product Portfolio
Table 82 Hangzhou NovaHealth Technology Co. Ltd.: News/Key Developments, 2022
Table 83 Laboratory Corporation of America Holdings: Company Snapshot
Table 84 Laboratory Corporation of America Holdings: Financial Performance, FY 2022 and 2023
Table 85 Laboratory Corporation of America Holdings: Product Portfolio
Table 86 Laboratory Corporation of America Holdings: News/Key Developments, 2024
Table 87 Lepu Medical Technology (Beijing) Co. Ltd.: Company Snapshot
Table 88 Lepu Medical Technology (Beijing) Co. Ltd.: Financial Performance, FY 2022 and 2023
Table 89 Lepu Medical Technology (Beijing) Co. Ltd.: Product Portfolio
Table 90 Mainz Biomed N.V.: Company Snapshot
Table 91 Mainz Biomed N.V.: Financial Performance, FY 2022 and 2023
Table 92 Mainz Biomed N.V.: Product Portfolio
Table 93 Mainz Biomed N.V.: News/Key Developments, 2023 and 2024
Table 94 Novigenix SA: Company Snapshot
Table 95 Novigenix SA: Product Portfolio
Table 96 Olympus Corp.: Company Snapshot
Table 97 Olympus Corp.: Financial Performance, FY 2022 and 2023
Table 98 Olympus Corp.: Product Portfolio
Table 99 Olympus Corp.: News/Key Developments, 2024
Table 100 Quest Diagnostics Inc.: Company Snapshot
Table 101 Quest Diagnostics Inc.: Financial Performance, FY 2022 and 2023
Table 102 Quest Diagnostics Inc.: Product Portfolio
Table 103 Quest Diagnostics Inc.: News/Key Developments, 2023
Table 104 QuidelOrtho Corp.: Company Snapshot
Table 105 QuidelOrtho Corp.: Financial Performance, FY 2022 and 2023
Table 106 QuidelOrtho Corp.: Product Portfolio
Table 107 QuidelOrtho Corp.: News/Key Developments, 2024

List of Figures

Summary Figure Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Region, 2023
Figure 1 Five-Year Survival Rates, by Colorectal Cancer Location
Figure 2 Market Dynamics of Colorectal Cancer Screening and Diagnostic Testing
Figure 3 Emerging Technologies in the Colorectal Cancer Screening and Diagnostic Testing Service Market
Figure 4 Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, 2023
Figure 5 Global Market for Colonoscopy and Sigmoidoscopy Tests, by Region, 2021-2029
Figure 6 Global Market for Stool DNA Tests, by Region, 2021-2029
Figure 7 Global Market for Blood Based/Biomarker Tests, by Region, 2021-2029
Figure 8 Global Market for Fecal Occult Blood Tests (FOBT), by Region, 2021-2029
Figure 9 Global Market for Fecal Immunochemical Tests (FIT), by Region, 2021-2029
Figure 10 Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Region, 2023
Figure 11 North American Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Country, 2023
Figure 12 U.S. Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 13 Canadian Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 14 Mexican Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 15 European Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Country, 2023
Figure 16 German Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 17 U.K. Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 18 French Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 19 Italian Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 20 Spanish Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 21 Rest of European Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 22 Asia-Pacific Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Country, 2023
Figure 23 Chinese Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 24 Japanese Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 25 Indian Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 26 South Korean Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 27 Australian Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 28 Rest of Asia-Pacific Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 29 Total Number of Key Developments and Strategies, January 2022-November 2024
Figure 30 Partnerships and Collaborations, January 2022-November 2024
Figure 31 Acquisitions, January 2022-November 2024
Figure 32 Business Expansions, January 2022-November 2024
Figure 33 Funding and Grants, January 2022-November 2024
Figure 34 Product Approvals, Launches and Expansions, January 2022-November 2024
Figure 35 Regulatory and Legal Activities, January 2022-November 2024
Figure 36 Medicare and Insurance Coverage, January 2022-November 2024
Figure 37 Snapshot of ESG Pillars
Figure 38 Danaher Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 39 Danaher Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 40 Eiken Chemical Co. Ltd.: Revenue Shares, by Product Type, FY 2023
Figure 41 Exact Sciences Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 42 Exact Sciences Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 43 Fujifilm Holdings Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 44 Fujifilm Holdings Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 45 Guardant Health: Revenue Shares, by Business Unit, FY 2023
Figure 46 Guardant Health: Revenue Shares, by Country/Region, FY 2023
Figure 47 Hangzhou NovaHealth Technology Co. Ltd.: Revenue Shares, by Business Unit, FY 2022
Figure 48 Hangzhou NovaHealth Technology Co. Ltd.: Revenue Shares, by Country/Region, FY 2022
Figure 49 Laboratory Corporation of America Holdings: Revenue Shares, by Business Unit, FY 2023
Figure 50 Laboratory Corporation of America Holdings: Revenue Shares, by Country/Region, FY 2023
Figure 51 Lepu Medical Technology (Beijing) Co. Ltd.: Revenue Shares, by Business Unit, FY 2023
Figure 52 Olympus Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 53 Olympus Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 54 Quest Diagnostics Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 55 QuidelOrtho Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 56 QuidelOrtho Corp.: Revenue Shares, by Country/Region, FY 2023

Companies Mentioned

Danaher Corp.
Diacarta
Eiken Chemical Co. Ltd.
Exact Sciences Corp.
Freenome Holdings Inc.
Fujifilm Holdings Corp.
GI-View
Guardant Health
Hangzhou Novahealth Technology Co. Ltd.
Laboratory Corporation of America Holdings
Lepu Medical Technology (Beijing) Co. Ltd.
Mainz Biomed N.V.
Novigenix SA
Olympus Corp.
Quest Diagnostics Inc.
Quidelortho Corp.

Table Information

Report Attribute	Details
No. of Pages	166
Published	February 2025
Forecast Period	2024 - 2029
Estimated Market Value ( USD ) in 2024	$ 40 Billion
Forecasted Market Value ( USD ) by 2029	$ 46.1 Billion
Compound Annual Growth Rate	2.9%
Regions Covered	Global
No. of Companies Mentioned	16

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4442EUR$4,650USD£3,727GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€5330EUR$5,580USD£4,472GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€6397EUR$6,696USD£5,367GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€7676EUR$8,035USD£6,440GBP

Report Scope

Regional analysis is further segregated:

The report includes:

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Colorectal Cancer Screening and Diagnostics Market - A Global and Regional Analysis: Focus on Type, End User, Region, and Competitive Landscape, Pricing Analysis, Testing Volume - Analysis and Forecast, 2023-2033

Colorectal Cancer Screening Market - Forecasts from 2023 to 2028

Colorectal Cancer Screening Market Report 2024

Colorectal Cancer Screening and Diagnostic Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028

Colorectal Cancer Screening Market Analysis & Forecast to 2024-2034